Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

GPhC responds to PDA member concerns on trainee assessment exam June 2023

The General Pharmaceutical Council (GPhC) has responded to Pharmacists' Defence Association (PDA)'s concern over trainee assessment exam June 2023.

PDA members expressed concerns about the questions in the clinical exam including the high level of difficulty, a lack of clarity of wording, and a feeling that some questions were outside the scope of the curriculum. Following contact from members this morning the PDA has spoken with the GPhC and raised members’ views with them.


In response GPhC said: “The registration assessment is one of the ways we test that trainee pharmacists can demonstrate that they understand how to apply knowledge appropriately and in a timely way, to make professional judgements in pharmacy practice. It also tests trainees’ number sense and that they are able to perform the calculations necessary to practice as a pharmacist.

The published registration assessment framework sets out the areas that are covered by the assessment, including expectations of a pharmacy professional and the skills required in practice. Questions related to clinical care are mapped to therapeutic areas which are weighted and the assessment includes questions on high-risk drugs, paediatric patients, and calculations.

To make sure that each registration assessment is consistent, the question papers are set and moderated by an appointed body, the Board of Assessors. All decisions about questions, papers, candidates, and pass marks are made by the board.

The standard a trainee must achieve to pass the registration assessment remains the same across each sitting. The pass mark for each paper varies from sitting to sitting depending on the combined difficulty of the questions. This is to make sure that the assessment is fair and that the standard is maintained.

The pass mark for the assessment is arrived at using evidence-based standard-setting processes – recognised methods used by examination bodies to derive pass marks for papers in order to apply a set standard across sittings.

When preparing assessment papers, a standard-setting panel of pharmacists assesses the standard of each question in each of the papers. Before agreeing pass marks for each paper, the Board of Assessors undertakes a full review of the performance of the questions, and the papers as a whole. This includes statistical analysis of the relative level of difficulty.”

The PDA has previously made recommendations for change to the GPhC to improve the logistical organisation and delivery of the examinations which have been implemented in full such as IT equipment testing, face-to-face training for invigilators, and GPhC staff presence at every centre. It believes these changes have improved the experience for all candidates.

However, there are a number of recommendations the PDA has made which have not yet been implemented and may also make a difference to the candidates.

The PDA provides a quality revision programme and live sessions to support trainee and potential pharmacist members with their preparations free of charge through PDA Education.

The PDA has requested the GPhC to examine and extend the provision of their revision support for trainees, and to develop a quality assurance process for external commercial providers of their revision resources.

Collette Bradford, PDA Director of Organising and Engagement said, “We have worked positively with the GPhC for a number of years to improve the experience of the online assessment for trainees and potential pharmacists. We would now like this work to extend to pre-assessment revision resources and quality assurance of the support and providers in order that all trainees and potential pharmacists have an equal opportunity to pass the assessment examinations.

"PDA would welcome further discussions with the regulator regarding an appropriate assessment process fit for the future and on improving and extending both the period and quality of the mentoring supervision experience for those who will qualify as independent prescribers from 2026. As an organisation with over 37,000 members, we are well placed to work with the regulator to help to develop an assessment process which is fair to all and is fit for purpose to develop pharmacists who are able to give the best care to patients.”

More For You

Home cervical screening kits in England

Government data states that around five million women are still not attending cervical screenings

Getty Images

Home cervical screening kits launched in England

Key Summary

  • NHS England has launched at-home cervical screening kits to improve uptake among women aged 25 to 64.
  • The discreet kits aim to overcome barriers like embarrassment and increase screening rates from 68.8 per cent towards the 80 per cent target.
  • Early diagnosis through home testing is expected to boost survival rates and help tackle cervical cancer for all communities.

NHS England has created an innovative at-home human papillomavirus (HPV) testing, for women who are yet to take cervical screening service.

Keep ReadingShow less
NHS warns doctors using unapproved  AI Software

NHS England has demanded that GPs and hospitals stop using artificial intelligence software that could breach data protection rules.

iStock

NHS warns doctors against use of unapproved AI software

Key Summary

  • NHS wants GPs and hospitals to stop using dubious artificial intelligence software during patient meetings
  • It had in April urged the doctors to use AI for notetaking using Ambient Voice Technology software
  • But it now claims that many AVT suppliers, who fail to meet NHS governance standards, are selling them to doctors
  • British Medical Association officials want the NHS to help doctors choose the safe AVT software

Doctors have been warned against the use of AI software that does not meet minimum standards to record and transcribe patient meetings.

Keep ReadingShow less
Mother holding newborn baby during early postnatal care in NHS maternity setting

Mother with newborn in NHS maternity care

Getty Images

Failing maternity services leads to nation-wide inquiry

Key Summary
  • Wes Streeting has ordered a national inquiry into failing NHS maternity and neonatal services
  • The review will start this summer, focusing first on the worst-performing units
  • A second phase will examine the entire system and propose national improvements
  • The inquiry will tackle racial inequalities and maternity mortality disparities

Health Secretary Wes Streeting has commissioned a nation-wide inquiry due to the rise in the number of failing maternity and neonatal services in the country.

NHS trusts such as Morecambe Bay, Shrewsbury and Telford, East Kent, Nottingham and Leeds are some of the names on the worst-performing list.

Keep ReadingShow less
UK globally competitive in life sciences

The Industrial Strategy has identified eight high-growth potential sectors, including life sciences.

iStock

Key test will be to make UK globally competitive in life sciences: ABPI

Key Summary

  • The Industrial Strategy has identified life sciences as one of its high-growth potential sectors
  • ABPI wants the UK to become a leading centre for life sciences research and development
  • It wants the government to move quickly from planning to delivery

The Association of the British Pharmaceutical Industry (ABPI) has welcomed the government’s new Industrial Strategy, but said the key test for life sciences will be whether it can return the UK to international competitiveness.

Keep ReadingShow less
Screening newborn babies for rare diseases will involve sequencing their complete DNA

Screening newborn babies for rare diseases will involve sequencing their complete DNA

iStock

DNA test for all babies to study disease risk

Key Summary

  • The DNA of newborn babies will be sequenced using blood samples from their umbilical cord
  • The government will invest £650m in DNA research for all patients by 2030
  • Genomics and AI would be used for faster diagnoses

Children born in England will have their DNA mapped to screen for hundreds of diseases under the NHS plan for the next 10 years.

Keep ReadingShow less